Efficacy and safety of biosimilar IFX (CT-P13) and adalimumab in patients with active fistulizing perianal Crohn’s disease naïve to anti-TNF therapy: preliminary results from the POLIBD study
English
e-ISSN: 2544-1361
ICV 2023: 100.00
MNiSW: 20.00
